Enzolytics Inc.
OTC: ENZC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Steven Sharabura
- Employees
- 1
- Headquarters
- Plano, United States
- IPO year
- 2009
- Market cap
- $3.9M
- Website
- https://enzolytics.com
Loading ENZC…
Loading profile data…Frequently asked questions about ENZC
What does Enzolytics Inc. (ENZC) do?
Enzolytics Inc., a biopharmaceutical company based in Plano, Texas, is dedicated to the development and commercialization of its specialized protein-based therapies. Its primary focus is on addressing severe infectious illnesses. The company possesses patented anti-HIV treatments that have successfully completed clinical testing. Additionally, E...
Where does ENZC trade?
Enzolytics Inc. (ENZC) trades on the Other OTC.
What sector is ENZC in?
Enzolytics Inc. (ENZC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Enzolytics Inc.?
Steven Sharabura is the chief executive officer of Enzolytics Inc. (ENZC).
Where is Enzolytics Inc. headquartered?
Enzolytics Inc. is headquartered in United States.
Does ENZC pay a dividend?
Enzolytics Inc. (ENZC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ENZC go public?
Enzolytics Inc. (ENZC) completed its initial public offering in 2009.